======= SLC35A3 ======= == Gene Information == * **Official Symbol**: SLC35A3 * **Official Name**: solute carrier family 35 member A3 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=23443|23443]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9Y2D2|Q9Y2D2]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SLC35A3&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SLC35A3|Open PubMed]] * **OMIM**: [[https://omim.org/entry/605632|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a UDP-N-acetylglucosamine transporter found in the golgi apparatus membrane. In cattle, a missense mutation in this gene causes complex vertebral malformation. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2012]. * **UniProt Summary**: Uridine diphosphate-N-acetylglucosamine (UDP-GlcNAc) transporter in the Golgi apparatus. May supply UDP-GlcNAc as substrate for Golgi-resident glycosyltransferases that generate branching of diantennary oligosaccharides. {ECO:0000269|PubMed:10393322}. |Nuc sug transp| |UAA| |UDP-N-acetylglucosamine transmembrane transporter activity| |UDP-N-acetylglucosamine transmembrane transport| |pyrimidine nucleotide-sugar transmembrane transport| |nucleotide-sugar transmembrane transport| |UDP-N-acetylglucosamine metabolic process| |nucleotide-sugar metabolic process| |amino sugar metabolic process| |integral component of Golgi membrane| |carbohydrate derivative transport| |carbohydrate transport| |nucleobase-containing compound transport| |anion transmembrane transport| |organic anion transport| |nucleobase-containing small molecule metabolic process| |anion transport| |Golgi membrane| |ion transmembrane transport| |Golgi apparatus| |carbohydrate derivative metabolic process| |transmembrane transport| |ion transport| |small molecule metabolic process| |nitrogen compound transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp22|MLN-4924 2μM R00 exp22]]|1.72| |[[:results:exp51|Nifuroxazide 1μM R01 exp51]]|1.81| |[[:results:exp8|Brefeldin A 0.02μM R00 exp8]]|1.92| |[[:results:exp50|Nicotinamide 2000μM R01 exp50]]|1.92| |[[:results:exp391|Pomalidomide 20μM R07 exp391]]|1.94| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 1/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 15421 * **Expression level (log2 read counts)**: 5.61 {{:chemogenomics:nalm6 dist.png?nolink |}}